Skip to main content
Premium Trial:

Request an Annual Quote

Centagenetix, Boston University and Boston Medical Center in Centenarian Genetics Study

NEW YORK, Dec. 5-Centagenetix will work with Boston University and Boston Medical Center to study the DNA of centenarians in the hopes of understanding diseases of aging, the company said in a statement today.


Centagenetix, a new company devoted to studying the genetics of aging, is working on a project to collect DNA from people worldwide who have reached the age of 100. It already has relationships with the Okinawan Centenarian Study, the Abyad Medical Center in Lebanon, and the Associazione Longevita in Naples.


Under the agreement with Boston University, both parties will share access to their sets of samples. Centagenetix gets exclusive commercial rights to develop treatments or diagnostics emerging from this research. Boston University and Boston Medical Center may use the discoveries in their research and will get royalties on any Centagenetix sales.


Boston University and Boston Medical Center jointly host the New England Centenarian study, an effort to understand the slowed process of aging in very old people.


The three partners are currently involved in furthering studies on the role of a gene on chromosome 4 in longevity.


Centagenetix is based in Cambridge, Mass. Boston Medical Center is a private nonprofit medical center affiliated with Boston University.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.